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Materials
All commercially available reagents were used without further purification. Water was doubly distilled before use.
Doxorubicin•HCl (≥95%) and N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate
(≥99%) were purchased from I 2 CNS LLC (Switzerland) . N,N-dimethylformamide (99.8%, extra dry, AcroSeal®) was purchased from ACROS Organics (Switzerland). Silica gel (230-400 mesh) was purchased from Merck KGaA.
Fmoc-Lys-OH was purchased from Novabiochem, Switzerland. Sodium triacetoxyborohydride (97%), 2-pyridinecarboyaldehyde (99%), methanesulfonyl chloride (>99.7%), N,N-diisopropylethylamine (≥99%), piperidine (99%), triethylamine (>99%), 1,8-diazabicyclo [5.4 .0]undec-7-ene (DBU, 98%), sodium bicarbonate (99%), potassium carbonate (99%), magnesium sulfate (97%), potassium nitrate (≥99%), sodium L-tartrate dibasic dihydrate (≥99%), sodium tetraborate decahydrate (≥99%), dichloromethane, dichloroethane, chloroform, methanol, deoxyribonucleic acid sodium salt from calf thymus (at 1 mg per vial), Sephadex G10 and HPLC solvents were purchased from Sigma Aldrich (Switzerland). Trifluoroacetic acid (>99.5%, HPLC grade) was purchased from Alfa Aesar. Purified hTopoII α was purchased from Affimetrix (Santa Clara, CA). hTopoII β was received from Austin C.A. and purified as published previously. 1 High purity supercoiled plasmid NTC7485E-U6-shRNA containing triplex forming insert 2 
Characterization
Fluorescence spectra were recorded on a PerkinElmer Luminescence Spectrophotometer LS50B. IR spectra were recorded on a PerkinElmer Spectrum Two FT-IR spectrometer, equipped with a SPECAC Golden Gate TM ATR. 1 H-NMR and 13 C-NMR were recorded on a Bruker DRX 500 MHz spectrometer. 1 H and 13 C chemical shifts were referenced with the residual solvent resonances relative to TMS. Spectra were fully assigned to structures with the help of various experiments (1D NOE, 1H-COSY, C,H-Correlation and 13C-DEPT). Electrospray-ionization mass spectrometry (ESI-MS) was performed on a Bruker HCT TM spectrometer. High-resolution mass spectrometry (HR-MS) was performed on a Thermo DFS double-focusing system (ThermoFisher Scientific, Germany). Values are reported for the 187 Re isotope. Inductively-coupled plasma mass spectrometry (ICP-MS) measurements were performed on an Agilent QQQ 8800 Triple quad, equipped with a standard x-lens setting, nickel cones and a "micro-S4 mist" quartz nebulizer. Microwave reactions were perfomed using a Biotage Initiator+ Robot Eight instrument.
Fluorescence anisotropy measurements were made using a Pherastar plate reader (BMG Labtech, Cary, NC) equipped with a fluorescence polarization optics module with a 540 nm excitation filter and 590 nm filters for parallel and perpendicular emission. All filters had 20 nm bandwiths.
Preparative HPLC was performed on a Varian ProStar 320 system, using a Dr. Maisch Reprosil C18 100-7 (40 x 250 mm) column. HPLC solvents were 0.1% trifluoroacetic acid and acetonitrile, HPLC grade.
Analytical HPLC was performed on a Merck Hitachi L7000 system, equipped with a L-7400 UV-detector and an inline radio-detector Berthold FlowStar LB513, using an analytical Macherey-Nagel Nucleosil C18 5 µm (4.6 x 250 mm) column. HPLC solvents were 0.1% trifluoroacetic acid (solvent A) and acetonitrile, HPLC grade (solvent B). 
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Methods
Distribution coefficient
The distribution coefficient (logD octanol/PBS ) was determined according to a modification of a method published previously. 3 In short, purified compounds were dissolved in phosphate buffer (10 mM, pH 7.4), previously saturated with n-octanol, to a volume of about 1 ml (activity concentration of ca. 1 MBq/ml). An equal volume of n-octanol (presaturated with 10 mM phosphate buffer) was then added and the solution was vortexed for 1 min. After an equilibration time of 5 h, the radioactivity in the two phases was evaluated by a gamma counter. The logD octanol/PBS is calculated according to equation (1) and expressed as the mean ± standard deviation of five individual measurements.
(1)
DNA-binding affinity
DNA solutions were prepared by dissolving 1 mg ctDNA (sodium salt, Sigma Aldrich) in PBS buffer (10 mM, pH 7.4). The exact concentration was determined by UV/VIS by using ε 260 = 6600 M -1 cm -1 per nucleotide. Test compounds were dissolved in PBS buffer (10 mM, pH 7.4) with NaCl (50 mM) at a constant concentration in a 3 ml cuvette and the afore mentioned solution of ctDNA (sodium salt) was then added in aliquots of max 2 µl. After every addition, samples were left to equilibrate at room temperature for 5-10 min and the emission spectrum (510 -700 nm) was recorded (excitation at 488 nm, excitation slit 5 nm, emission slit 20 nm, scan speed 100 nm/min) to give F obs = F 593nm . Additions of DNA were carried out until changes in the spectra were incremental, at that point the minimum fluorescence (F min ) was determined by using an excess of 50-100 equivalents of DNA/intercalator. 
Cell culture
The HeLa cervical cancer cell line was cultivated in DMEM medium (Gibco) supplemented with 5 % fetal calf serum (FCS, Gibco) 100 U/ml penicillin, 100 μg/ml streptomycin at 37°C and 6% CO 2 .
Chemotoxicity
Cytotoxicity of cisplatin, ADR, 4 and 6 on HeLa cells was assessed by a fluorometric cell viability assay using
Resazurin (Promocell GmbH). Cells were plated in triplicates in 96-well plates at a density of 4 × 10 3 cells/well in 100 µl, 24 h prior to treatment. Cells were then treated with increasing concentrations of test samples for 48 h. The medium was replaced by complete medium containing resazurin (0.2 mg/ml final concentration) and incubated for 4 h at 37 °C. Finally, the fluorescence of the highly red fluorescent resorufin product was quantified (590 nm emission with 540 nm excitation wavelength) in a SpectraMax M5 microplate Reader.
Fluorescence microscopy
Cellular localization of ADR, 4 and 6 was performed by confocal fluorescence microscopy. HeLa cells were grown on 18 mm Menzel-gläser coverslips in 2 ml complete medium at a density of 1 × 10 5 cells per ml and incubated for 2 h with the compounds (4: 20 µM, 6: 20 µM, ADR: 1 µM). Cells were fixed in formaldehyde solution (4% formaldehyde in PBS) and mounted on slides in Vectashield ® solution containing DAPI prior to viewing by confocal microscopy on a CLSM Leica SP5 microscope. ADR and its derivatives were excited at 488 nm and emission above 600 nm was recorded.
Human topoisomerase II α and β inhibition assay
Sample preparation
Inhibitors 4 and 6 were dissolved at 20 mM in DMSO. Serial 2-fold dilutions were prepared and transferred to a black polystyrene 384-well assay plate (Thermo Fisher Scientific/Matrix Technology Corp., Hudson, NH) at 2% of the final assay volume (0.6 µl). ATP-dependent DNA relaxation assays in 30 µl contained either 3 U/ml hTOPOII α or 90 ng/ml hTOPOII β, 85 µg/ml (10 nM) supercoiled plasmid and 1 mM ATP in 50 mM Tris-HCl (pH 7.5), 150 mM KCl, 5% (v/v) glycerol, 10 mM MgCl 2 , 1 mM dithiothreitol, 0.002% (v/v) Brij-35, and 200 nM bovine serum albumin (BSA). To allow for correction for interference in fluorescence measurements by compounds using the method of Shapiro et al., 6 a duplicate plate was prepared in the same way except for the omission of the enzyme.
Reactions, conducted at room temperature, were quenched after 1 h by addition of 10 µl of a solution containing 40 S7 nM 5'-BODIPY-TMR-TTCTTCTTCT oligodeoxyribonuleotide in 300 mM NaCl and 300 mM sodium acetate, adjusted to pH 3.5 with acetic acid.
Fluorescence anisotropy measurements
Parallel and perpendicular fluorescence intensities were measured 1 h after addition of the quencher using a Pherastar plate reader (BMG Labtech, Cary, NC). The focal height was 7.0 mm and each measurement was the average of 50
flashes. The gains on parallel and perpendicular emission detectors were set to 1530 and 1558, respectively. After correcting parallel and perpendicular fluorescence measurements separately for interference by compounds 6 , the anisotropy was calculated. The %-inhibition at each compound concentration was calculated by:
where r is the anisotropy measurement in the presence of the inhibitor, r min is the anisotropy measurement in the absence of the enzyme, and r max is the anisotropy of the uninhibited enzyme. The IC 50 was calculated by nonlinear least-squares regression of the %-inhibition data to equation (6):
where [I] is the concentration of inhibitor and b is the Hill slope.
ICP-MS quantification
Sample preparation
To assess the cellular distribution of 99m Tc-complexes 3/5 and Re-complexes 4/6, compartmental fractionation studies were performed in HeLa cells. Adherent and confluent cells (T75 culture flask) were incubated with 99m Tc-complexes 3 and 5 (~12 MBq in culture medium) or Re-complex 4 and 6 (3 ml of a 20 M solution in culture medium) for 2 h at 37ºC and 5% CO 2 . The harvested cell suspension with 10-20 × 10 6 cells was split in 3 fractions (2 ml each), centrifuged at 850 g for 2 min at 4ºC (Centrifuge 5804R, Eppendorf) and cells washed twice with cold PBS to remove the unbound complex. An aliquot of 0.1 ml of cells suspension (whole-cell fraction) was separated for the cellular uptake determination. To obtain nuclear and mitochondrial fractions, the remaining cells suspension (1.9 ml) was treated with the "Mitochondria Isolation Kit for Cultured cells" (Thermo Scientific) according the manufacturer's protocol. Briefly, the pellet (about one third of total pellet: 2 × 10 7 cells) was resuspended with reagent A (0.8 ml/2 × 10 7 cells) supplemented with a cocktail of protease inhibitors (Roche, Basel, Switzerland), vortexed at medium speed for 5 s and incubated on ice for exactly 2 min. Reagent B (10 l / 2 × 10 7 cells) was added and the samples were vortexed at maximum speed for 5 seconds, incubated on ice and vortexed every minute for 5 min. Then, reagent C (0.8 ml/2 × 10 7 cells), supplemented with a cocktail of protease inhibitors, was added, and the cells suspension S8 centrifuged for 10 min at 700 g at 4ºC (Centrifuge 5417R, Eppendorf). The nucleus isolation steps were monitored by trypan blue staining under a phase contrast microscope. The resulting pellet corresponded to the nuclear fraction.
The supernatant, transferred to a new tube, was centrifuged for 15 min at 3'000 g at 4 ºC to remove the lysosomal and peroxisomal contaminants. The pellet, containing the isolated mitochondria, was again treated with reagent C (0.5 ml/2 × 10 7 cells) and centrifuged for 5 min at 12'000 g. The resulting mitochondria pellet (mitochondrial fraction)
as well as the whole-cell fraction and the nuclear fraction were directly counted in a dose calibrator (Berthold, LB2111) in the case of 3 and 5 or lyophilized and stored until determination of Re content by ICP-MS.
ICP-MS measurements
Rhenium was measured against a Re single element standard (Merck 170344.100) and verified by a control (Agilent5188-6524 PA Tuning 2). Rhenium content of the samples was determined by means of a 7-step serial dilution in the range between 0 and 300 ppb in Re (R> 0.99) with a background equivalent concentration of BEC:
9.4 ppt and a detection limit of DL: 2.6 ppt. The isotope Re 185 (37.4% abundance) Re 187 (62.6% abundance) was evaluated in "no-gas" mode and He-gas mode. Spiking the samples with untreated negative controls (to account for Fmoc-C1 as in Levadala et al. 7 , Armstrong et al. 8 Fmoc-Lys-OH (0.5 g, 1.35 mmol) was suspended in 10 ml of 1,2-dichloroethane. 
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This red powder was dried in vacuo and then washed out of the frit with CH 2 Cl 2 (4 ml). Removing the solvent yielded in a dark red solid. Fmoc-ADR-OMs. Fmoc-ADR was prepared according to a literature procedure. 10 Fmoc-ADR (20 mg, 26 µmol) was dissolved in dry CH 2 Cl 2 (2 ml) under a N 2 -atmosphere. To this solution was added TEA (50 µl, 0.365 mmol, 14 eq.) while it was cooled to 0°C with vigorous stirring to yield in a dark red mixture. Methanesulfonyl chloride (4.82 µl, 70 µmol, 2.7 eq.) was then added in tiny steps of 0.5 -1 µl per 3 min with a pipette and the progress of the reaction was carefully monitored by UPLC (gradient U1). After 95% consumption of Fmoc-ADR, MeOH (0.1 ml) was added to the reaction mixture to quench excess MsCl and the solvent was blown off in a N 2 -stream, yielding in a dark red solid. This solid was either used directly in the next step or purified by preparative HPLC (for analysis purposes) which yielded in a red foam after lyophilization. Yield: 16 mg (18 µmol, 69%).
UPLC-ESI + : R t = 1.55 min, area ≥98%, m/z= 861. Fmoc-ADR-OMs (9 mg, 10.6 µmol) was dissolved in anhydrous DMF (0.5 ml). HS-DAP (6.7 mg, 12.6 µmol, 1.2 eq.) was dissolved separately in anhydrous DMF (0. Caution! 99m Tc is a γ-emitter (E= 140 keV, t 1/2 = 6.02 h) which should only be handled in a licensed and appropriately shielded facility. Sodium boranocarbonate releases CO gas which is highly toxic, it is recommended to be handled only in ventilated hoods.
[ 99m Tc(OH 2 ) 3 (CO) 3 ] + modified from Alberto et al. 13, 14 A crimp sealable glass vial was charged with sodium boranocarbonate (4 mg, 38.5 µmol), sodium tartrate dihydrate (4 mg, 30.4 µmol) and sodium tetraborate decahydrate (4 mg, 18.5 µmol). Upon crimp sealing, this mixture was flushed with N 2 for 5 min before adding 99m TcO 4 -eluate (1 ml, ~ 10 -100 MBq) from a commercial generator. The resulting solution was heated at 95 °C for 20 min without stirring and thereafter cooled in a water bath. In order to normalize the overpressure, evolving gases were removed with a 1 ml disposable syringe. Excess sodium boranocarbonate was quenched via dropwise addition of 1M HCl to pH 2 and subsequent neutralizing by addition of 1M NaOH to pH 6-7.
[ 99m Tc(CO) 3 
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Supplementary Data
Chart S 26 -Fluorescence quenching of complexes 4 and 6 in the presence of ctDNA Figure 2 . Emission spectra (510-700 nm) of 4 at 0.7 µM and 6 at 2.8 µM in PBS buffer (10 mM, pH 7.48) with NaCl (50 mM). The initial fluorescence is quenched upon incremental addition of ctDNA.
Chart S 27 -Binding curves of ADR and complexes 4 and 6 with ctDNA 
